Brooklyn FI LLC Acquires Shares of 27,000 Tilray Inc (NASDAQ:TLRY)

Brooklyn FI LLC acquired a new stake in Tilray Inc (NASDAQ:TLRY) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 27,000 shares of the company’s stock, valued at approximately $36,000.

A number of other large investors have also recently made changes to their positions in TLRY. CIBC Asset Management Inc lifted its stake in shares of Tilray by 4.2% in the third quarter. CIBC Asset Management Inc now owns 908,098 shares of the company’s stock valued at $1,599,000 after buying an additional 36,799 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Tilray by 2.6% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,487,500 shares of the company’s stock valued at $2,617,000 after buying an additional 37,300 shares in the last quarter. Estate Counselors LLC lifted its stake in shares of Tilray by 40.0% in the third quarter. Estate Counselors LLC now owns 70,000 shares of the company’s stock valued at $123,000 after buying an additional 20,000 shares in the last quarter. Bank of Montreal Can lifted its stake in shares of Tilray by 0.3% in the third quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock valued at $3,787,000 after buying an additional 7,406 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its holdings in Tilray by 4.9% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 715,672 shares of the company’s stock worth $1,260,000 after acquiring an additional 33,194 shares during the last quarter. 9.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group lifted their price objective on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Tilray has an average rating of “Hold” and an average price target of $2.70.

Tilray Stock Down 5.0 %

Shares of NASDAQ:TLRY opened at $0.64 on Thursday. The company has a market capitalization of $602.16 million, a PE ratio of -2.14 and a beta of 2.13. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The business has a fifty day moving average price of $0.93 and a two-hundred day moving average price of $1.31. Tilray Inc has a 1 year low of $0.58 and a 1 year high of $2.97.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). The business had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business’s revenue was up 8.7% on a year-over-year basis. Analysts forecast that Tilray Inc will post -0.2 earnings per share for the current year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.